We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRC
351
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$4.34M 0.05%
39,525
+1,203
+3% +$126K
CDW icon
352
CDW
CDW
$17.1B
$4.32M 0.05%
37,221
+186
+0.5% +$20.2K
EXEL icon
353
Exelixis
EXEL
$12.5B
$4.32M 0.05%
182,110
+7,699
+4% +$178K
K
354
DELISTED
Kellanova
K
$4.32M 0.05%
69,675
+1,321
+2% +$79.9K
NTRS icon
355
Northern Trust
NTRS
$35B
$4.32M 0.05%
54,412
-203
-0.4% -$16.1K
OXY icon
356
Occidental Petroleum
OXY
$58.5B
$4.31M 0.05%
235,387
+5,123
+2% +$80.7K
COHR icon
357
Coherent
COHR
$69.6B
$4.3M 0.05%
91,064
+4,065
+5% +$161K
HQY icon
358
HealthEquity
HQY
$8.82B
$4.29M 0.05%
73,137
+3,596
+5% +$199K
ATR icon
359
AptarGroup
ATR
$8.47B
$4.27M 0.05%
38,118
+1,423
+4% +$151K
WEX icon
360
WEX
WEX
$6.48B
$4.26M 0.05%
25,839
+990
+4% +$136K
CHE icon
361
Chemed
CHE
$7.07B
$4.25M 0.05%
9,427
+237
+3% +$106K
RH icon
362
RH
RH
$3.41B
$4.25M 0.05%
17,067
+475
+3% +$86.1K
MXIM
363
DELISTED
Maxim Integrated Products
MXIM
$4.23M 0.05%
69,732
-20
-0% -$1.11K
LH icon
364
Labcorp
LH
$26.2B
$4.22M 0.05%
29,590
+456
+2% +$63.1K
TTC icon
365
Toro Company
TTC
$9.32B
$4.22M 0.05%
63,645
+2,454
+4% +$161K
PXD
366
DELISTED
Pioneer Natural Resource Co.
PXD
$4.21M 0.05%
43,116
+419
+1% +$36.9K
AMCR icon
367
Amcor
AMCR
$21.5B
$4.2M 0.05%
82,355
-1,167
-1% -$54.5K
CCMP
368
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$4.2M 0.05%
30,106
+1,188
+4% +$154K
OGS icon
369
ONE Gas
OGS
$5.05B
$4.2M 0.05%
54,447
+1,969
+4% +$159K
ODFL icon
370
Old Dominion Freight Line
ODFL
$44.1B
$4.19M 0.05%
49,356
-28
-0.1% -$2.13K
XPO icon
371
XPO
XPO
$24.5B
$4.18M 0.05%
156,468
+3,279
+2% +$78.5K
DAL icon
372
Delta Air Lines
DAL
$59.1B
$4.16M 0.05%
148,465
+97
+0.1% +$2.47K
TTWO icon
373
Take-Two Interactive
TTWO
$45.4B
$4.16M 0.05%
29,800
+627
+2% +$82K
Y
374
DELISTED
Alleghany Corp
Y
$4.16M 0.05%
8,498
+236
+3% +$122K
DAR icon
375
Darling Ingredients
DAR
$10B
$4.15M 0.05%
168,722
+5,450
+3% +$119K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.